
|Articles|December 2, 2001
- Pharmaceutical Technology-12-02-2001
- Volume 25
- Issue 12
Bioterrorism Threat Shines Spotlight on Drug Manufacturing
Author(s)Jill Wechsler
Anthrax contamination has put pharmaceutical quality and supply issues on the front page, along with patent and pricing policies.
Advertisement
Articles in this issue
over 24 years ago
E-Sourcing: Internet Facilitates Flexible Collaborationover 24 years ago
International Employment Survey 2001over 24 years ago
Outsourcing Outlookover 24 years ago
A Comprehensive Approach to Pharmaceutical Engineering TrainingAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What to Know About Regulations in June 2026
2
FDA Chooses 7 Companies for PreCheck Pilot
3
Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers
4
FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients
5




